Dr. William Thomas Purcell III, MD

Dr. Purcell practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Purcell's NPI, 1336187236, was assigned on June 3, 2006. Dr. Purcell graduated from Emory University School of Medicine in 1996. Dr. Purcell holds Washington license MD61207412.

Dr. Purcell's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Dr. Purcell's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Purcell to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Purcell practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Purcell's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Purcell is licensed in Washington.

CMS data shows 283 Medicare services from Dr. Purcell across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $21,416 for them. Every service was in an office.

CMS counts 74 Medicare patients who saw Dr. Purcell in 2024. The largest group is 65 to 74, with 30 patients. 66% of them have high blood pressure, and 64% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Purcell's median patient age at 67, with 48% women.

In 2024, Dr. Purcell wrote 221 Medicare Part D claims for 45 patients. 86% of them were for generic drugs. CMS names the drug for 104 of them, across 5 drugs with 11 or more claims each, at $27,847 in total drug cost. In 2023, CMS named 92 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Purcell for performance year 2024, reported through an alternative payment model (APM). Dr. Purcell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Purcell as offering telehealth.

Dmand AI links 27 papers to Dr. Purcell, published from 2015 to 2024. 2017 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Carcinoma, Non-Small-Cell Lung. Dr. Purcell has published most often in Oncology (Williston Park). Dr. Purcell's most frequent co-authors are Robert Doebele, MD, Paul Axtell Bunn, MD and David R. Camidge, MD.

Dmand AI links Dr. Purcell to 5 clinical trials. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Mesothelioma, Malignant. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 2 general payments to Dr. Purcell from 2 drug and device companies from 2020 to 2025. Education make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $68.

Dr. Purcell graduated from Emory University School of Medicine in 1996.